Long Grove Pharmaceuticals is set to introduce Sodium Bicarbonate Injection. The product is commonly used in critical care settings yet routinely found on the drug shortages list, the company said.

According to the Company, intravenous administration of the affected product could lead to “site specific infections as well as serious systemic infections which may be life-threatening.” SterRx, LLC ...

Exela Pharma Sciences is recalling an additional 14 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50mEq/50 mL vial, 20-count carton. In total, the Company is recalling 63 lots of the product due to ...

This leaflet answers some common questions about Sodium Bicarbonate Intravenous Infusion. It does not contain all the available information. It does not take the place of talking to your doctor or ...